Trials / Completed
CompletedNCT02378974
Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction
A Randomized, Double-blind, Placebo-controlled, Phase I/IIa Clinical Trial for Evaluation of Safety and Potential Therapeutic Effects After Intravenous Transplantation of Human Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Cerebral Infarction Disease
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- CHABiotech CO., Ltd · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the safety and the potential therapeutic effects per dose of Cordstem-ST Intravenous Transplantation in Cerebral Infarction subjects
Detailed description
Cohort 1 : Cordstem-ST cells or Placebo on day 0 Cohort 2: Cordstem-ST cells or Placebo on day 0 and day 7
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Cordstem-ST | |
| BIOLOGICAL | Placebo |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2015-03-04
- Last updated
- 2024-04-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02378974. Inclusion in this directory is not an endorsement.